EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

Eskil Eskilsson, Gro V. Rosland, Krishna M. Talasila, Stian Knappskog, Olivier Keunen, Andrea Sottoriva, Sarah Foerster, Gergely Solecki, Torfinn Taxt, Radovan Jirik, Sabrina Fritah, Patrick N. Harter, Kristjan Välk, Jubayer Al Hossain, Justin V. Joseph, Roza Jahedi, Halala S. Saed, Sara G. Piccirillo, Inma Spiteri, Philipp EuskirchenGrazia Graziani, Thomas Daubon, Morten Lund-Johansen, Per Øyvind Enger, Frank Winkler, Christoph A. Ritter, Simone P. Niclou, Colin Watts, Rolf Bjerkvig, Hrvoje Miletic

Hematology & Oncology
Internal Medicine

Research output: Contribution to journal › Article › peer-review

74 Scopus citations

Sort by
Weight
Alphabetically

EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation

Fingerprint

Medicine & Life Sciences